Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$62 Mln
Revenue (TTM)
$14 Mln
Net Profit (TTM)
$-9 Mln
ROE
-0.3 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1.1
Industry P/E
--
EV/EBITDA
-1.3
Div. Yield
0 %
Debt to Equity
0
Book Value
$0
EPS
$0
Face value
--
Shares outstanding
59,480,100
CFO
$-182.74 Mln
EBITDA
$-195.10 Mln
Net Profit
$-185.34 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ReWalk Robotics - ADR
| -82.2 | -86.8 | -81.3 | -81.1 | -62.6 | -53.4 | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
ReWalk Robotics - ADR
| 2.4 | -38.2 | -6.8 | -38.9 | -50.4 | -84.0 | -60.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company... offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel. Read more
CEO & Director
Mr. Lawrence J. Jasinski BS, MBA
CEO & Director
Mr. Lawrence J. Jasinski BS, MBA
Headquarters
Yokneam Illit
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of ReWalk Robotics Ltd - ADR is $0.97 (NASDAQ) as of 01-Mar-2024 09:30 EDT. ReWalk Robotics Ltd - ADR has given a return of -62.63% in the last 3 years.
Since, TTM earnings of ReWalk Robotics Ltd - ADR is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
31,843.13
|
1,004.38
|
|
2022
|
-2.40
|
0.69
|
|
2021
|
-6.03
|
0.86
|
|
2020
|
-2.10
|
1.25
|
|
2019
|
-1.44
|
2.08
|
The 52-week high and low of ReWalk Robotics Ltd - ADR are Rs -- and Rs -- as of 05-Apr-2026.
ReWalk Robotics Ltd - ADR has a market capitalisation of $ 62 Mln as on 01-Mar-2024. As per SEBI classification, it is a company.
Before investing in ReWalk Robotics Ltd - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-5.80
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.